Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: If PTSC owned half the license - the the 3.5% should come only from TPL...

...may be my understanding is wrong, but i interpretate that brown gets his part beeing 3,5% of the gross (overall) revenue from tpls share, so ptsc share is not touched! no?

Share
New Message
Please login to post a reply